PBYI

Puma Biotechnology Inc (PBYI)

About Puma Biotechnology Inc (PBYI)

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Details

Daily high

$2.85

Daily low

$2.72

Price at open

$2.73

52 Week High

$7.73

52 Week Low

$2.13

Market cap

139.8M

Dividend yield

0.00%

Volume

293,540

Avg. volume

284,402

P/E ratio

15.58

Puma Biotechnology Inc News